Day One Biopharmaceuticals, Inc. (DAWN)

9.955 +1.20 (+13.64%) USD  |  NASDAQ  |  Dec 18, 14:37
More

Day One Biopharmaceuticals Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for DAWN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Mersana Therapeutics, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Lantheus Holdings, Inc. Upgrade
Travere Therapeutics, Inc. Upgrade
Xenetic Biosciences, Inc. Upgrade